B lymphocytes from patients with chronic lymphocytic leukemia contain signal transducer and activator of transcription (STAT) 1 and STAT3 constitutively phosphorylated on serine residues

Journal of Clinical Investigation

Volumn 100, Issue 12, 1997, Pages 3140-3148

  Frank, David A ^a   Mahajan, Sudipta ^b   Ritz, Jerome ^b  

^a DANA FARBER CANCER INSTITUTE   (United States)

^b NONE

Author keywords

Cancer; H7; Kinase; Phosphatase; Transcription factor

Indexed keywords

1 (5 ISOQUINOLINESULFONYL) 2 METHYLPIPERAZINE; MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHATASE; PHOSPHOTRANSFERASE; STAT1 PROTEIN; STAT3 PROTEIN; TRANSCRIPTION FACTOR;

ARTICLE; B LYMPHOCYTE; CHRONIC LYMPHATIC LEUKEMIA; DEPHOSPHORYLATION; HUMAN; HUMAN CELL; IMMUNOBLOTTING; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION;

EID: 0031436969     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI119869     Document Type: Article

References (32)

1. Rozman, C., and E. Montserrat. 1995. Chronic lymphocytic leukemia. N. Engl. J. Med. 333:1052-1057.
2. Caligaris-Cappio, F. 1996. B-chronic lymphocytic leukemia: a malignancy of anti-self B cells. Blood. 87:2615-2620.
3. Juliusson, G., and G. Gahrton. 1993. Cytogenetics in CLL and related disorders. Bailliere's Clin. Hematol. 6:821-848.
4. Daley, G.Q., and D. Baltimore. 1988. Transformation of an interleukin 3-dependent hemalopoietic cell line by the chronic myelogenous leukemia-specific P210bcr/abl protein. Proc. Natl. Acad. Sci. USA. 85:9312-9316.
5. Palacios, R., and M. Steinmetz. 1985. I1-3-dependent mouse clones that express B-220 antigen, contain Ig genes in germ-line configuration, and generate B lymphocytes in vivo. Cell. 41:727-734.
6. Schindler, C., and J.E. Darnell, Jr. 1995. Transcriptional responses to polypeptide ligands: the JAK-STAT pathway. Annu. Rev. Biochem. 64:621-651.
7. Frank, D.A., and M.E. Greenberg. 1996. Signal transduction pathways activated by ciliary neurotrophic factor and related cytokines. Perspect. Dev. Neurobiol. 4:3-18.
8. Shuai, K., G.R. Stark, I.M. Kerr, and J.E. Darnell, Jr. 1993. A single phosphotyrosine residue of Stat91 required for gene activation by interferons-γ. Science. 261:1744-1746.
9. Wen, Z., Z. Zhong, and J.E. Darnell, Jr. 1995. Maximal activation of transcription by Stat1 and Stat3 requires both tyrosine and serine phosphorylation. Cell. 82:241-250.
10. Zhang, X., J. Blenis, H.-C. Li, C. Schindler, and S. Chen-Kiang. 1995. Requirement of serine phosphorylation for formation of Stat-promoter complexes. Science. 267:1990-1994.
11. Gouilleux-Gruart, V., F. Gouilleux, C. Desaint, J.-F. Claisse, J.-C. Capiod, J. Delobel, R. Weber-Nordt, I. Dusanter-Fourt, F. Dreyfus, B. Groner, and L. Prin. 1996. STAT-related transcription factors are constitutively activated in peripheral blood cells from acute leukemia patients. Blood. 87:1692-1697.
12. Weber-Nordt, R.M., C. Egen, J. Wehinger, W. Ludwig, V. Gouilleux-Gruart, R. Mertelsmann, and J. Finke. 1996. Constitutive activation of STAT proteins in primary lymphoid and myeloid leukemia cells and in Epstein-Barr virus (EBV)-related lymphoma cell lines. Blood. 88:809-816.
13. Migone, T-S., J.-X. Lin, A. Cereseto, J.C. Mulloy, J.J. O'Shea, G. Franchini, and W.J. Leonard. 1995. Constitutively activated Jak-STAT pathway in T cells transformed with HTLV-I. Science. 269:79-81.
14. Carlesso, N., D.A. Frank, and J.D. Griffin. 1996. Tyrosyl phosphorylation and DNA-hinding activity of STAT proteins in hematopoietic cell lines transformed by Bcr/Abl. J. Exp. Med. 183:811-820.
15. Frank, D.A., and L. Varticovski. 1996. BCR/abl leads to the constitutive activation of Stat proteins, and shares an epitope with tyrosine phosphorylated Stats. Leukemia. 10:1724-1730.
16. Robertson, M.J., K.J. Cochran, C. Cameron, J.M. Le, R. Tantravahi, and J. Ritz. 1996. Characterization of a cell line, NKL, derived from an aggressive human natural killer cell leukemia. Exp. Hematol. (Charlottesv.). 24:406-415.
17. Frank, O.A., M. Robertson, A. Bonni, J. Ritz, and M.E. Greenberg. 1995. IL-2 signaling involves the phosphorylation of novel Stat proteins. Proc. Natl. Acad. Sci. USA. 92:7779-7783.
18. Sattler, M., M.A. Durstin, D.A. Frank, K. Okuda, K. Kaushansky, R. Salgia, and J.D. Griffin. 1995. The thrombopoietin receptor c-MPL activates JAK2 and TYK2 tyrosine kinases. Exp. Hematol. (Charlottesv.). 23:1040-1048.
19. Smith, K.A. 1988. Interleukin-2: inception, impact, and implications. Science. 240:1169-1176.
20. Tanner, J.E., and G. Tosato. 1992. Regulation of B-cell growth and immunoglobulin gene transcription by interleukin-6. Blood. 79:452-459.
21. Clark-Lewis, I., J.S. Sanghera, and S.L. Pelech. 1991. Definition of a consensus sequence for peptide substrate recognition by p44mpk, the meiosis-activated myelin basic protein kinase. J. Biol. Chem. 266:15180-15184.
22. Gonzalez, F.A., D.L. Raden, and R.J. Davis. 1991. Identification of substrate recognition determinants for human ERK1 and ERK2 protein kinases. J. Biol. Chem. 266:22159-22163.
23. Hidaka, H., M. Inagaki, S. Kawamoto, and Y. Sasaki. 1984. Isoquinolinesulfonamides, novel and porent inhibitors of cyclic nucleotide dependent protein kinase and protein kinase C. Biochemistry. 23:5036-5041.
24. Bialojan, C., and A. Takai. 1988. Inhibitory effect of a marine-sponge toxin, okadaic acid, on protein phosphatases. Specificity and kinetics. Biochem. J. 256:283-290.
25. David, M., E.I. Petricoin, C. Benjamin, R. Pine, M.J. Weber, and A.C. Larner. 1995. Requirement for MAP kinase (ERK2) activity in interferon α- and interferon β-stimulated gene expression through STAT proteins. Science. 269:1721-1723.
26. Dudley, D.T., L. Pang, S.J. Decker, A.J. Bridges, and A.R. Saltiel. 1995. A synthetic inhibitor of the mitogen-activated protein kinase cascade. Proc. Natl. Acad. Sci. USA. 92:7686-7689.
27. Alessi, D.R., A. Cuenda, P. Cohen, D.T. Dudley, and A.R. Saltiel. 1995. PD 098059 is a specific inhibitor of the activation of mitogen-activated protein kinase kinase in vitro and in vivo. J. biol. Chem. 270:27489-27494.
28. Erikson, R.L. 1991. Structure, expression, and regulation of protein kinases involved in the phosphorylation of ribosomal protein S6. J. Biol. Chem. 266:6007-6010.
29. Chung, J., C.J. Kuo, G.R. Crabtree, and J. Blenis. 1992. Rapamycin-FKBP specifically blocks growth-dependent activation of and signaling by the 70 kd S6 protein kinases. Cell. 69:1227-1236.
30. Price, D.J., J.R. Grove, V. Calvo, J. Avruch, and B.E. Bierer. 1992. Rapamycin-induced inhibition of the 70-kilodalton S6 protein kinase. Science. 257: 973-977.
31. Kwok, R.P.S., J.R. Lundblad, J.C. Chrivia, J.P. Richards, H.P. Bachinger, R.G. Brennan, S.G.E. Roberts, M.R. Green, and R.H. Goodman. 1994. Nuclear protein CBP is a coactivator for the transcription factor CREB. Nature. 370:223-226.
32. Chrivia, J.C., R.P.S. Kwok, N. Lamb, M. Hagiwara, M.R. Montminy, and R. Goodman. 1993. Phosphorylated CREB binds specifically to the nuclear protein CBP. Nature. 365:855-859.